BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27824230)

  • 1. Aggressive epidermotropic cutaneous CD8+ lymphoma.
    DI Meo N; Stinco G; Trevisini S; Croatto M; Trevisan G
    G Ital Dermatol Venereol; 2016 Dec; 151(6):730-732. PubMed ID: 27824230
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggressive epidermotropic cutaneous CD8+ (Berti's) lymphoma.
    Webber NK; Harwood C; Goldsmith P; Cerio R; Wells P; Kazmi M; Russell-Jones MR; Morris S; Robson A
    Clin Exp Dermatol; 2010 Jun; 35(4):e210-2. PubMed ID: 20518920
    [No Abstract]   [Full Text] [Related]  

  • 3. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma.
    Morse DC; Park KE; Chitsazzadeh V; Li S; Young K; Gunther JR; Dabaja BS; Duvic M
    Int J Gynecol Pathol; 2021 May; 40(3):229-233. PubMed ID: 33741766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma on upper eyelid.
    Lee J; Yang YJ; Kim JI; Park JH; Kim WS
    Indian J Ophthalmol; 2015 Jan; 63(1):81-2. PubMed ID: 25686076
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation.
    Nofal A; Abdel-Mawla MY; Assaf M; Salah E
    J Am Acad Dermatol; 2012 Oct; 67(4):748-59. PubMed ID: 22226429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of lymphomatoid papulosis type D to CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma.
    Gill P; Chia J; Street L; Mahe E
    Histopathology; 2021 Sep; 79(3):442-444. PubMed ID: 34050974
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary Cutaneous CD8+ T-cell Lymphoma, an Indolent and Locally Aggressive Form Mimicking Paronychia.
    Beggs SM; Friedman BJ; Kornreich D; Okon L; Alpdogan O; Shi W; Sahu J
    Am J Dermatopathol; 2018 Apr; 40(4):e52-e56. PubMed ID: 28984695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma clinically simulating pyoderma gangrenosum.
    Wang Y; Li T; Tu P; Wu LS; Zhu XJ
    Clin Exp Dermatol; 2009 Oct; 34(7):e261-2. PubMed ID: 19438529
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary cutaneous aggressive epidermotropic CD8 positive cytotoxic T-cell lymphoma of the ear.
    Fika Z; Karkos PD; Badran K; Williams RE
    J Laryngol Otol; 2007 May; 121(5):503-5. PubMed ID: 17166330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse rash with associated ulceration.
    Day A; Staples CG; Fiala K
    Cutis; 2016 Nov; 98(5):E14-E15. PubMed ID: 28040815
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febrile ulceronecrotic Mucha Habermann disease mimicking aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: a diagnostic challenge.
    Lalevee S; Ortonne N; Hotz C; Schlemmer F; Beldi-Ferchiou A; Delfau-Larue MH; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S
    Eur J Dermatol; 2018 Dec; 28(6):834-835. PubMed ID: 30325315
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
    Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
    Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
    Kim SK; Kim YC; Kang HY
    J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous CD8+ epidermotropic cytotoxic T-cell lymphoma with aggressive course].
    Poszepczynska-Guigné E; Jagou M; Wechsler J; Dieng MT; Revuz J; Bagot M
    Ann Dermatol Venereol; 2006 Mar; 133(3):253-6. PubMed ID: 16800177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8
    Deenen NJ; Koens L; Jaspars EH; Vermeer MH; Willemze R; de Rie MA; Bekkenk MW
    Br J Dermatol; 2019 Feb; 180(2):411-412. PubMed ID: 30259963
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary cutaneous CD8+ aggressive epidermotropic T-cell lymphoma mimicking pyoderma gangrenosum.
    Flora A; Gibson M; Toon C; Rawson R; Lowe P
    Indian J Dermatol Venereol Leprol; 2021; 88(1):90-92. PubMed ID: 34951938
    [No Abstract]   [Full Text] [Related]  

  • 18. Six-year-old girl with primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Kikuchi Y; Kashii Y; Gunji Y; Morimoto A; Masuzawa A; Takatsuka Y; Fujita E; Komine M; Ohtsuki M; Matsubara D; Kobayashi C; Sakurai A; Yanase K; Kato K; Koike K; Tsuchida M; Momoi MY
    Pediatr Int; 2011 Jun; 53(3):393-6. PubMed ID: 21696508
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell ('Berti') lymphoma after administration of adalimumab.
    Jacks SM; Taylor BR; Rogers RP; Ralston JS; Metcalf JS; Lazarchick J
    J Am Acad Dermatol; 2014 Sep; 71(3):e86-7. PubMed ID: 25128139
    [No Abstract]   [Full Text] [Related]  

  • 20. CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma?
    Miyauchi T; Abe R; Morita Y; Adachi M; Shiba K; Hamade Y; Saito N; Nishimura M; Ibata M; Okada K; Shigematsu A; Endo T; Kawai K; Teshima T; Shimizu H
    Acta Derm Venereol; 2015 Nov; 95(8):1024-5. PubMed ID: 25792011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.